{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:06:18Z","timestamp":1774433178263,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate characterization of the breast cancer-related lymphedema (BCLR) population is essential to understand its pathophysiology and develop predictive models for identifying at-risk patients and implementing tailored preventive microsurgical strategies. Key factors influencing BCRL severity and progression remain unclear. This study characterizes patients with BCRL seeking microsurgical treatment and evaluates the impact of oncological treatment intensity on lymphedema severity and progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cohort study was conducted at an outpatient tertiary lymphedema clinic between 2017 and 2023. BCRL severity was assessed at intake by a lymphedema-specialized plastic surgeon using International Society of Lymphology staging and indocyanine green lymphography with near-infrared fluorescence imaging (ICG-NIFI). Data were collected during scheduled medical evaluations and analyzed retrospectively. Exploratory analysis investigated associations between oncological treatment intensity and BCRL severity and progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 163 consecutive female patients with BCRL were included. Lymphedema severity varied significantly, with no consistent link between severity and time since onset. A significant association was found between axillary lymph node dissection (ALND) and ICG-NIFI stages (p&lt;0.001). However, no significant associations were found between oncological treatment intensity\u2014surgery, radiotherapy, systemic treatment\u2014and BCRL severity and progression. Analyses further revealed associations between lymphedema severity, body mass index, postmenopausal status, and clinical course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides a comprehensive profile of patients with BCRL seeking microsurgical treatment, revealing variable lymphedema progression patterns. Oncological treatment intensity did not appear to influence BCRL severity or progression, suggesting that these may depend more on biological predisposition. These findings enhance BCRL understanding and highlight the importance of precise patient characterization, laying the foundation for targeted, individually tailored preventive microsurgical interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18694-8","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:33:38Z","timestamp":1763476418000},"page":"2019-2027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Breast Cancer-Related Lymphedema (BCRL): Comprehensive Characterization of Patients Seeking Microsurgical Treatment"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2411-2820","authenticated-orcid":false,"given":"Daphne","family":"van Gemert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise Marie","family":"Beelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Mos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurentine","family":"van Egdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert-Jan","family":"van Gaalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linetta","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Margreet","family":"van Dishoeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"van der Oest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalibor","family":"Vasilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"18694_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010.","journal-title":"Breast."},{"issue":"6","key":"18694_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500\u201315. https:\/\/doi.org\/10.1016\/S1470-2045(13)70076-7.","journal-title":"Lancet Oncol."},{"issue":"4","key":"18694_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.sap.0000257149.42922.7e","volume":"59","author":"AG Warren","year":"2007","unstructured":"Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: A comprehensive review. Ann Plast Surg. 2007;59(4):464\u201372. https:\/\/doi.org\/10.1097\/01.sap.0000257149.42922.7e.","journal-title":"Ann Plast Surg."},{"issue":"6","key":"18694_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jaad.2017.03.022","volume":"77","author":"AA Grada","year":"2017","unstructured":"Grada AA, Phillips TJ. Lymphedema: Pathophysiology and clinical manifestations. J Am Acad Dermatol. 2017;77(6):1009\u201320. https:\/\/doi.org\/10.1016\/j.jaad.2017.03.022.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"18694_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jvsv.2020.04.008","volume":"8","author":"TFJ O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell TFJ, Allison GM, Melikian R, Iafrati MD. A systematic review of the quality of clinical practice guidelines for lymphedema, as assessed using the appraisal of guidelines for research and evaluation II instrument. J Vasc Surg Venous Lymphat Disord. 2020;8(4):685\u201392. https:\/\/doi.org\/10.1016\/j.jvsv.2020.04.008.","journal-title":"J Vasc Surg Venous Lymphat Disord."},{"issue":"3","key":"18694_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5306\/wjco.v5.i3.241","volume":"5","author":"MR Fu","year":"2014","unstructured":"Fu MR. Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol. 2014;5(3):241\u20137. https:\/\/doi.org\/10.5306\/wjco.v5.i3.241.","journal-title":"World J Clin Oncol."},{"issue":"4","key":"18694_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21037\/gs.2017.11.04","volume":"7","author":"TC Gillespie","year":"2018","unstructured":"Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: Risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379\u2013403. https:\/\/doi.org\/10.21037\/gs.2017.11.04.","journal-title":"Gland Surg."},{"issue":"1","key":"18694_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41523-021-00276-y","volume":"7","author":"MG J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen MG, Toyserkani NM, Hansen FG, Bygum A, S\u00f8rensen JA. The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. NPJ Breast Cancer. 2021;7(1):70. https:\/\/doi.org\/10.1038\/s41523-021-00276-y.","journal-title":"NPJ Breast Cancer."},{"issue":"7","key":"18694_CR9","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/pon.3201","volume":"22","author":"MR Fu","year":"2013","unstructured":"Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: A systematic review of literature from 2004 to 2011. Psychooncology. 2013;22(7):1466\u201384. https:\/\/doi.org\/10.1002\/pon.3201.","journal-title":"Psychooncology."},{"key":"18694_CR10","doi-asserted-by":"publisher","first-page":"174550652090572","DOI":"10.1177\/1745506520905720","volume":"16","author":"Y Sun","year":"2020","unstructured":"Sun Y, Shigaki CL, Armer JM. The influence of breast cancer related lymphedema on women\u2019s return-to-work. Womens Health (Lond). 2020;16:1745506520905720. https:\/\/doi.org\/10.1177\/1745506520905720.","journal-title":"Womens Health (Lond)."},{"issue":"2","key":"18694_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/SAP.0b013e31824f20d4","volume":"71","author":"F Boccardo","year":"2013","unstructured":"Boccardo F, Fulcheri E, Villa G, et al. Lymphatic microsurgery to treat lymphedema: Techniques and indications for better results. Ann Plast Surg. 2013;71(2):191\u20135. https:\/\/doi.org\/10.1097\/SAP.0b013e31824f20d4.","journal-title":"Ann Plast Surg."},{"issue":"1","key":"18694_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/micr.20214","volume":"26","author":"C Campisi","year":"2006","unstructured":"Campisi C, Davini D, Bellini C, et al. Lymphatic microsurgery for the treatment of lymphedema. Microsurgery. 2006;26(1):65\u20139. https:\/\/doi.org\/10.1002\/micr.20214.","journal-title":"Microsurgery."},{"issue":"5","key":"18694_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000004291","volume":"10","author":"WKF Hill","year":"2022","unstructured":"Hill WKF, Deban M, Platt A, Rojas-Garcia P, Jost E, Temple-Oberle C. Immediate lymphatic reconstruction during axillary node dissection for breast cancer: A systematic review and meta-analysis. Plast Reconstr Surg Glob Open. 2022;10(5):e4291. https:\/\/doi.org\/10.1097\/GOX.0000000000004291.","journal-title":"Plast Reconstr Surg Glob Open."},{"issue":"1","key":"18694_CR14","first-page":"3","volume":"53","author":"Executive Committee of the International Society of Lymphology","year":"2020","unstructured":"Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology. Lymphology. 2020;53(1):3\u201319.","journal-title":"Lymphology."},{"issue":"7","key":"18694_CR15","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/cancers13071540","volume":"13","author":"MG J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen MG, Toyserkani NM, Hansen FCG, Thomsen JB, S\u00f8rensen JA. Prospective validation of indocyanine green lymphangiography staging of breast cancer-related lymphedema. Cancers (Basel). 2021;13(7):1540. https:\/\/doi.org\/10.3390\/cancers13071540.","journal-title":"Cancers (Basel)."},{"issue":"6","key":"18694_CR16","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2522\/ptj.20100087","volume":"91","author":"N Devoogdt","year":"2011","unstructured":"Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens M. Lymphoedema functioning, disability and health questionnaire (lymph-ICF): Reliability and validity. Phys Ther. 2011;91(6):944\u201357. https:\/\/doi.org\/10.2522\/ptj.20100087.","journal-title":"Phys Ther."},{"issue":"10","key":"18694_CR17","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336. https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","journal-title":"Qual Life Res."},{"key":"18694_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2474-4-11","volume":"4","author":"C Gummesson","year":"2003","unstructured":"Gummesson C, Atroshi I, Ekdahl C. The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: Longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord. 2003;4:11\u201311. https:\/\/doi.org\/10.1186\/1471-2474-4-11.","journal-title":"BMC Musculoskelet Disord."},{"key":"18694_CR19","doi-asserted-by":"publisher","unstructured":"Chung KC, Pillsbury MS, Walters MR, Hayward RA. Reliability and validity testing of the michigan hand outcomes questionnaire. J Hand Surg. 1998;23(4):575\u2013587. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0363502398800427. https:\/\/doi.org\/10.1016\/S0363-5023(98)80042-7.","DOI":"10.1016\/S0363-5023(98)80042-7"},{"key":"18694_CR20","unstructured":"Posit team PS, PBC. Rstudio: Integrated development environment for R. 2024."},{"key":"18694_CR21","unstructured":"Netherlands Cancer Registry &, Netherlands Comprehensive Cancer Organisation (IKNL). NCR data & figures. https:\/\/iknl.nl\/en\/ncr\/ncr-data-figures. Accessed 19-05-2025."},{"issue":"6","key":"18694_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500\u201315. https:\/\/doi.org\/10.1016\/S1470-2045(13)70076-7.","journal-title":"Lancet Oncol."},{"issue":"2","key":"18694_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12609-017-0237-8","volume":"9","author":"HE Sayegh","year":"2017","unstructured":"Sayegh HE, Asdourian MS, Swaroop MN, et al. Diagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: Past, present, and future directions. Curr Breast Cancer Rep. 2017;9(2):111\u201321. https:\/\/doi.org\/10.1007\/s12609-017-0237-8.","journal-title":"Curr Breast Cancer Rep."},{"issue":"2","key":"18694_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10549-015-3408-1","volume":"151","author":"MN Swaroop","year":"2015","unstructured":"Swaroop MN, Ferguson CM, Horick NK, et al. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: Results from a large prospective cohort. Breast Cancer Res Treat. 2015;151(2):393\u2013403. https:\/\/doi.org\/10.1007\/s10549-015-3408-1.","journal-title":"Breast Cancer Res Treat."},{"issue":"30","key":"18694_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016563","volume":"98","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang X, Chen S, et al. Taxane-based chemotherapy and risk of breast cancer-related lymphedema: Protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(30):e16563. https:\/\/doi.org\/10.1097\/MD.0000000000016563.","journal-title":"Medicine (Baltimore)."},{"issue":"2","key":"18694_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijrobp.2023.04.020","volume":"117","author":"GE Naoum","year":"2023","unstructured":"Naoum GE, Taghian AG. Regional lymph node radiation is not the main risk factor for breast cancer related lymphedema: Stop chasing radiation doses, fractionation or techniques-focus on axillary surgery de-escalation or prevention. Int J Radiat Oncol Biol Phys. 2023;117(2):461\u20134. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.04.020.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"18694_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000522243","volume":"17","author":"M Abouegylah","year":"2022","unstructured":"Abouegylah M, Elemary O, Munir A, Gouda MY, Arafat WO, Elzawawy S. Evaluation of the effect of axillary radiotherapy dose and the development of lymphedema in breast cancer patients. Breast Care (Basel). 2022;17(4):364\u201370. https:\/\/doi.org\/10.1159\/000522243.","journal-title":"Breast Care (Basel)."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18694-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18694-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18694-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:39:38Z","timestamp":1770899978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18694-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["18694"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18694-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"A non-WMO declaration was provided by the Medical Ethics Review Committee of the Erasmus Medical Center (MEC-2022-0569).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}